Ionis Pharmaceuticals 2021 Investor Day

Ionis Pharmaceuticals' 2021 Investor Day presentation from December 9, 2021, covering the company's pipeline, commercialization efforts, and therapeutic potential of key programs including SPINRAZA®, eplontersen, olezarsen, and donidalorsen. The presentation includes forward-looking statements regarding business performance, financial guidance, and development progress across the company's antisense technology platform.